» Articles » PMID: 35992857

Integrated Multi-omics Analysis Identifies As a Predictor of Recurrence and a Regulator of Telomere Maintenance in Hepatocellular Carcinoma

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Aug 22
PMID 35992857
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and has a high recurrence rate. Accurate prediction of recurrence risk is urgently required for tailoring personalized treatment programs for individual HCC patients in advance. In this study, we analyzed a gene expression dataset from an HCC cohort with 247 samples and identified five genes including , , , , and as the variables for the prediction of HCC recurrence, especially the early recurrence. The Cox model and risks score were validated in two public HCC cohorts (GSE76427 and The Cancer Genome Atlas (TCGA)) and one cohort from Huashan Hospital, which included a total of 641 samples. Moreover, the multivariate Cox regression analysis revealed that the risk score could serve as an independent prognostic factor in the prediction of HCC recurrence. In addition, we found that , , and were significantly upregulated in HCC of the two validation cohorts, and had significantly higher expression levels than another four genes in malignant cells, suggesting that might play key roles in malignant cells. The cell line analysis revealed that ENY2 could promote cell cycle progression, cell proliferation, migration, and invasion. The functional analysis of the genes correlated with revealed that ENY2 might be involved in telomere maintenance, one of the fundamental hallmarks of cancer. In conclusion, our data indicate that ENY2 may regulate the malignant phenotypes of HCC activating telomere maintenance.

Citing Articles

Single-cell RNA sequencing revealed potential targets for immunotherapy studies in hepatocellular carcinoma.

Xie Z, Huang J, Li Y, Zhu Q, Huang X, Chen J Sci Rep. 2023; 13(1):18799.

PMID: 37914817 PMC: 10620237. DOI: 10.1038/s41598-023-46132-w.


VEGF/Nrp1/HIF-1α promotes proliferation of hepatocellular carcinoma through a positive feedback loop.

Wang Y, Zheng K, Hu Y, Salameen H, Zhu Z, Wu F Med Oncol. 2023; 40(12):339.

PMID: 37875691 DOI: 10.1007/s12032-023-02202-7.


High expression of GPR50 promotes the proliferation, migration and autophagy of hepatocellular carcinoma cells in vitro.

Zhao W, Xi L, Yu G, Wang G, Chang C J Cell Commun Signal. 2023; 17(4):1435-1447.

PMID: 37378811 PMC: 10713896. DOI: 10.1007/s12079-023-00772-9.


Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications.

Fernandez-Palanca P, Payo-Serafin T, Mendez-Blanco C, San-Miguel B, Tunon M, Gonzalez-Gallego J Clin Mol Hepatol. 2023; 29(2):293-319.

PMID: 36726054 PMC: 10121286. DOI: 10.3350/cmh.2022.0425.

References
1.
De Marco C, Zoppoli P, Rinaldo N, Morganella S, Morello M, Zuccala V . Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer. Transl Oncol. 2021; 14(3):101013. PMC: 7846933. DOI: 10.1016/j.tranon.2021.101013. View

2.
Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View

3.
Calderaro J, Ziol M, Paradis V, Zucman-Rossi J . Molecular and histological correlations in liver cancer. J Hepatol. 2019; 71(3):616-630. DOI: 10.1016/j.jhep.2019.06.001. View

4.
Pfab A, Bruckmann A, Nazet J, Merkl R, Grasser K . The Adaptor Protein ENY2 Is a Component of the Deubiquitination Module of the Arabidopsis SAGA Transcriptional Co-activator Complex but not of the TREX-2 Complex. J Mol Biol. 2018; 430(10):1479-1494. DOI: 10.1016/j.jmb.2018.03.018. View

5.
Ma L, Hernandez M, Zhao Y, Mehta M, Tran B, Kelly M . Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer. Cancer Cell. 2019; 36(4):418-430.e6. PMC: 6801104. DOI: 10.1016/j.ccell.2019.08.007. View